332 related articles for article (PubMed ID: 24905997)
1. Autophagy regulates the therapeutic potential of mesenchymal stem cells in experimental autoimmune encephalomyelitis.
Dang S; Xu H; Xu C; Cai W; Li Q; Cheng Y; Jin M; Wang RX; Peng Y; Zhang Y; Wu C; He X; Wan B; Zhang Y
Autophagy; 2014 Jul; 10(7):1301-15. PubMed ID: 24905997
[TBL] [Abstract][Full Text] [Related]
2. Autophagy promotes apoptosis of mesenchymal stem cells under inflammatory microenvironment.
Dang S; Yu ZM; Zhang CY; Zheng J; Li KL; Wu Y; Qian LL; Yang ZY; Li XR; Zhang Y; Wang RX
Stem Cell Res Ther; 2015 Dec; 6():247. PubMed ID: 26670667
[TBL] [Abstract][Full Text] [Related]
3. Autophagy inhibition via Becn1 downregulation improves the mesenchymal stem cells antifibrotic potential in experimental liver fibrosis.
Wang HY; Li C; Liu WH; Deng FM; Ma Y; Guo LN; Kong H; Hu KA; Liu Q; Wu J; Sun J; Liu YL
J Cell Physiol; 2020 Mar; 235(3):2722-2737. PubMed ID: 31508820
[TBL] [Abstract][Full Text] [Related]
4. The effects of transplanted mesenchymal stem cells treated with 17-b estradiol on experimental autoimmune encephalomyelitis.
Heidari Barchi Nezhad R; Asadi F; Abtahi Froushani SM; Hassanshahi G; Kaeidi A; Khanamani Falahati-Pour S; Hashemi Z; Mirzaei MR
Mol Biol Rep; 2019 Dec; 46(6):6135-6146. PubMed ID: 31555971
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells.
Luz-Crawford P; Kurte M; Bravo-Alegría J; Contreras R; Nova-Lamperti E; Tejedor G; Noël D; Jorgensen C; Figueroa F; Djouad F; Carrión F
Stem Cell Res Ther; 2013 Jun; 4(3):65. PubMed ID: 23734780
[TBL] [Abstract][Full Text] [Related]
6. Rapamycin Augments Immunomodulatory Properties of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis.
Togha M; Jahanshahi M; Alizadeh L; Jahromi SR; Vakilzadeh G; Alipour B; Gorji A; Ghaemi A
Mol Neurobiol; 2017 May; 54(4):2445-2457. PubMed ID: 26971291
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells engineered to express selectin ligands and IL-10 exert enhanced therapeutic efficacy in murine experimental autoimmune encephalomyelitis.
Liao W; Pham V; Liu L; Riazifar M; Pone EJ; Zhang SX; Ma F; Lu M; Walsh CM; Zhao W
Biomaterials; 2016 Jan; 77():87-97. PubMed ID: 26584349
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells differentially modulate effector CD8+ T cell subsets and exacerbate experimental autoimmune encephalomyelitis.
Glenn JD; Smith MD; Calabresi PA; Whartenby KA
Stem Cells; 2014 Oct; 32(10):2744-55. PubMed ID: 24911892
[TBL] [Abstract][Full Text] [Related]
9. Intranasal administration of small extracellular vesicles derived from mesenchymal stem cells ameliorated the experimental autoimmune encephalomyelitis.
Fathollahi A; Hashemi SM; Haji Molla Hoseini M; Tavakoli S; Farahani E; Yeganeh F
Int Immunopharmacol; 2021 Jan; 90():107207. PubMed ID: 33290966
[TBL] [Abstract][Full Text] [Related]
10. The effect of transplanted human Wharton's jelly mesenchymal stem cells treated with IFN-γ on experimental autoimmune encephalomyelitis mice.
Torkaman M; Ghollasi M; Mohammadnia-Afrouzi M; Salimi A; Amari A
Cell Immunol; 2017 Jan; 311():1-12. PubMed ID: 27697286
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of insulin-like growth factor 1 exerts a protective effect on hypoxic injury of aged BM-MSCs: role of autophagy.
Yang M; Wen T; Chen H; Deng J; Yang C; Zhang Z
Stem Cell Res Ther; 2018 Oct; 9(1):284. PubMed ID: 30359321
[TBL] [Abstract][Full Text] [Related]
12. Autophagy: a potential key contributor to the therapeutic action of mesenchymal stem cells.
Ceccariglia S; Cargnoni A; Silini AR; Parolini O
Autophagy; 2020 Jan; 16(1):28-37. PubMed ID: 31185790
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal Stem Cells Attenuated Blood-Brain Barrier Disruption via Downregulation of Aquaporin-4 Expression in EAE Mice.
Liu Y; Ma Y; Du B; Wang Y; Yang GY; Bi X
Mol Neurobiol; 2020 Sep; 57(9):3891-3901. PubMed ID: 32613467
[TBL] [Abstract][Full Text] [Related]
14. Disparate Effects of Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis and Cuprizone-Induced Demyelination.
Glenn JD; Smith MD; Kirby LA; Baxi EG; Whartenby KA
PLoS One; 2015; 10(9):e0139008. PubMed ID: 26407166
[TBL] [Abstract][Full Text] [Related]
15. Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination.
Payne NL; Sun G; McDonald C; Layton D; Moussa L; Emerson-Webber A; Veron N; Siatskas C; Herszfeld D; Price J; Bernard CC
Cell Transplant; 2013; 22(8):1409-25. PubMed ID: 23057962
[TBL] [Abstract][Full Text] [Related]
16. TRAIL-Mediated Suppression of T Cell Receptor Signaling Inhibits T Cell Activation and Inflammation in Experimental Autoimmune Encephalomyelitis.
Chyuan IT; Tsai HF; Wu CS; Sung CC; Hsu PN
Front Immunol; 2018; 9():15. PubMed ID: 29403497
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.
Zappia E; Casazza S; Pedemonte E; Benvenuto F; Bonanni I; Gerdoni E; Giunti D; Ceravolo A; Cazzanti F; Frassoni F; Mancardi G; Uccelli A
Blood; 2005 Sep; 106(5):1755-61. PubMed ID: 15905186
[TBL] [Abstract][Full Text] [Related]
18. IL17/IL17RA as a Novel Signaling Axis Driving Mesenchymal Stem Cell Therapeutic Function in Experimental Autoimmune Encephalomyelitis.
Kurte M; Luz-Crawford P; Vega-Letter AM; Contreras RA; Tejedor G; Elizondo-Vega R; Martinez-Viola L; Fernández-O'Ryan C; Figueroa FE; Jorgensen C; Djouad F; Carrión F
Front Immunol; 2018; 9():802. PubMed ID: 29760692
[TBL] [Abstract][Full Text] [Related]
19. Synergistic and Superimposed Effect of Bone Marrow-Derived Mesenchymal Stem Cells Combined with Fasudil in Experimental Autoimmune Encephalomyelitis.
Yu JW; Li YH; Song GB; Yu JZ; Liu CY; Liu JC; Zhang HF; Yang WF; Wang Q; Yan YP; Xiao BG; Ma CG
J Mol Neurosci; 2016 Dec; 60(4):486-497. PubMed ID: 27573128
[TBL] [Abstract][Full Text] [Related]
20. Early intervention with gene-modified mesenchymal stem cells overexpressing interleukin-4 enhances anti-inflammatory responses and functional recovery in experimental autoimmune demyelination.
Payne NL; Dantanarayana A; Sun G; Moussa L; Caine S; McDonald C; Herszfeld D; Bernard CC; Siatskas C
Cell Adh Migr; 2012; 6(3):179-89. PubMed ID: 22568986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
